From rabies to transmissible spongiform encephalopathies: An immune-mediated microbial trigger involving molecular mimicry could be the answer

Medical Hypotheses

Volumn 68, Issue 1, 2007, Pages 113-124

  Ebringer, Alan ^a   Rashid, Taha ^a   Jawad, Noor ^a   Wilson, Clyde ^b   Thompson, Edward J ^c   Ettelaie, Camille ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b King Edward VII Memorial Hospital   (Bermuda)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ANTIGEN; MYELIN PROTEIN; PRION PROTEIN; RABIES VACCINE;

ACINETOBACTER; ALLERGIC ENCEPHALOMYELITIS; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN HOMOGENATE; CREUTZFELDT JAKOB DISEASE; EPIDEMIC; HUMAN; HUMORAL IMMUNITY; IMMUNITY; INFLAMMATION; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; RABIES; SCRAPIE; VACCINATION;

ACINETOBACTER; ANIMALIA; BACTERIA (MICROORGANISMS); BOS TAURUS;

EID: 33750626212     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.06.017     Document Type: Article

References (89)

1. Fu Z.F. Rabies and rabies research: past, present and future. Vaccine 15 Suppl. (1997) s20-s24
2. Warrell M.J., and Warrell D.A. Rhabdoviruses: rabies and rabies-related viruses. In: Warrell D.A., Cox T.M., Firth J.D., and Benz E.J. (Eds). Oxford textbook of medicine (2003), Oxford University Press, Oxford 367-376
3. Pearce J.M.S. Historical note: Louis Pasteur and rabies: a brief note. J Neurol Neurosurg Psychiatry 73 (2002) 82
4. Babes V., and Mironesco T. La paralysie ascendante mortelle survenue après le traitement antirabique. C R Soc Biol 64 (1908) 964-966
5. Hurst E.W. The effect of the injection of normal brain emulsion into rabbits, with special reference to the aetiology of the paralytic accidents of antirabic treatment. J Hyg (Lond) 32 (1932) 3-44
6. Rivers T.M., Sprunt D.H., and Berry G.P. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med 58 (1933) 39-54
7. Rivers T.M., and Schwentker F.F. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J Exp Med 61 (1935) 689-702
8. Willenborg D.O., and Prowse S.J. Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis. J Neuroimmunol 5 (1983) 99-109
9. Wiktor T.J., Fernandes M.V., and Koprowski H. Cultivation of rabies virus in human diploid cell strain WI-38. J Immunol 93 (1964) 353-366
10. Arnason B.G. Neuroimmunology. N Engl J Med 316 (1987) 406-408
11. Kabat E.A., Wolf A., and Bezer A.E. The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvants. J Exp Med 85 (1947) 117-130
12. Gold R., Linington C., and Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129 (2006) 1953-1971
13. Eylar E.H., Salk J., Beveridge G.C., and Brown L.W. Experimental allergic encephalomyelitis: an encephalitogenic basic protein from bovine myelin. Arch Biochem Biophys 132 (1969) 34-48
14. Raine C.S. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 50 (1984) 608-635
15. Linington C., Morgan B.P., Scolding N.J., Wilkins P., Piddlesden S.J., and Compston D.A. The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 112 (1989) 895-911
16. Sakuma H., Kohyama K., Park I.K., Miyakoshi A., Tanuma N., and Matsumoto Y. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced dymyelinating disease in LEW. 1AV1 rats. Brain 127 (2004) 2201-2213
17. Lassmann H., and Wisniewski H.M. Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis. Arch Neurol 36 (1979) 490-497
18. Storch M.K., Stefferl A., Brehm U., et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 8 (1998) 681-694
19. Kalman B., Albert R.H., and Leist T.P. Genetics of multiple sclerosis: determinants of autoimmunity and neurodegeneration. Autoimmunity 35 (2002) 225-234
20. Kabat E.A., Glusman M., and Knaub V. Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods. Am J Med 4 (1948) 653-662
21. Sharief M.K., and Thompson E.J. Intrathecal immunoglobulin M synthesis in multiple sclerosis. Relationship with clinical and cerebrospinal fluid parameters. Brain 114 (1991) 181-195
22. Warren K.G., and Catz I. A correlation between cerebrospinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis. Ann Neurol 21 (1987) 183-189
23. Hughes L.E., Bonell S., Natt R.S., et al. Antibody responses to Acinetobacter spp. and Pseudomonas aeruginosa in multiple sclerosis: prospects for diagnosis using the myelin-Acinetobacter-neurofilament antibody index. Clin Diagn Lab Immunol 8 (2001) 1181-1188
24. Reindl M., Linington C., Brehm U., et al. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 122 (1999) 2047-2056
25. Hughes L.E., Smith P.A., Bonell S., et al. Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis. J Neuroimmunol 144 (2003) 105-115
26. Silber E., Semra Y.K., Gregson N.A., and Sharief M.K. Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit. Neurology 58 (2002) 1372-1381
27. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Medical progress: multiple sclerosis. N Engl J Med 343 (2000) 938-952
28. Cruz M., Olsson T., Ernerudh J., Hojeberg B., and Link H. Immunoblot detection of oligoclonal antimyelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis. Neurology 37 (1987) 1515-1519
29. Berger T. Multiple sclerosis. Autoimmunity 37 (2004) 321-324
30. Chapman M.D., Hughes L.E., Wilson C.D., Namnyak S., Thompson E.J., and Giovannoni G. No evidence for production of intrathecal immunoglobulin G against Acinetobacter or Pseudomonas in multiple sclerosis. Eur Neurol 53 (2005) 27-31
31. Kaspar K.C., Stites D.P., Bowman K.A., Panitch H., and Prusiner S.B. Immunological studies of scrapie infection. J Neuroimmunol 3 (1982) 187-201
32. Mabbott N.A., and Bruce M.E. The immunobiology of TSE diseases. J Gen Virol 82 (2001) 2307-2318
33. Toh D.H., Gibbs C.J., Gajdusek D.C., Tuthill Dd., and Dahl D. The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from chimpanzees with kuru or Creutzfeldt-Jakob disease; a 62-kDa neurofilament-associated protein reacts with sera from sheep with natural scrapie. Proc Natl Acad Sci USA 82 (1985) 3894-3896
34. Klein M.A., Frigg R., Flechsig E., et al. A crucial role of B cells in neuroinvasive scrapie. Nature 390 (1997) 687-690
35. Tiwana H., Wilson C., Pirt J., Cartmell W., and Ebringer A. Autoantibodies to brain components and antibodies to Acinetobacter calcoaceticus are present in bovine spongiform encephalopathy. Infect Immun 67 (1999) 6591-6595
36. Wilson C., Hughes L., Rashid T., et al. Antibodies to prion and Acinetobacter peptide sequences in bovine spongiform encephalopathy. Vet Immunol Immunopathol 98 (2004) 1-7
37. Galvez S., Farcas A., and Monari M. Cerebrospinal fluid and serum immunoglobulins and C3 in Creutzfeldt-Jakob disease. Neurology 29 (1979) 1610-1612
38. Ebringer A., Rashid T., Wilson C., et al. Multiple sclerosis, sporadic Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: are they autoimmune diseases evoked by Acinetobacter microbes showing molecular mimicry to brain antigens?. J Nutr Environ Med 14 (2004) 293-302
39. Sotelo J., Gibbs C.J., and Gajdusek D.C. Autoantibodies against axonal neurofilaments in patients with kuru and Creutzfeldt-Jakob disease. Science 210 (1980) 190-193
40. Cossu G., Melis M., Molari A., et al. Creutzfeldt-Jakob disease associated with high titre of antithyroid autoantibodies: case report and literature review. Neurol Sci 24 (2003) 138-140
41. Giese A., Brown D.R., Groschup M.H., Feldmann C., Haist I., and Kretzschmar H.A. Role of microglia in neuronal cell death in prion disease. Brain Pathol 8 (1998) 449-457
42. Van Everbroeck B., Dewulf E., Pals P., Lubke U., Martin J.J., and Cras P. The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease. Neurobiol Aging 23 (2002) 59-64
43. Volkel D., Zimmermann K., Zerr I., et al. C-reactive protein and IL-6: new marker proteins for the diagnosis of CJD in plasma?. Transfusion 41 (2001) 1509-1514
44. Lewicki H., Tishon A., Homann D., et al. T cells infiltrate the brain in murine and human transmissible spongiform encephalopathies. J Virol 77 (2003) 3799-3808
45. Kovacs G.G., Gasque P., Strobel T., et al. Complement activation in human prion disease. Neurobiol Dis 15 (2004) 21-28
46. Anderson R.M., Donnelly C.A., Ferguson N.M., et al. Transmission dynamics and epidemiology of BSE in British cattle. Nature 382 (1996) 779-788
47. Wells G.A., Scott A.C., Johnson C.T., et al. A novel progressive spongiform encephalopathy in cattle. Vet Rec 121 (1987) 419-420
48. Purdey M. Are organo phosphates involved in the causation of bovine spongiform encephalopathy (BSE)? Hypothesis based upon literature review and limited trials on BSE cattle. J Nutr Med 4 (1994) 43-82
49. Ebringer A., Pirt J., and Wilson C. Bovine spongiform encephalopathy (BSE): could be an autoimmune disease produced by bacteria showing 'molecular mimicry' with bovine/ovine brain antigens. Immunol Lett 56 (1997) 312-313
50. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 216 (1982) 136-144
51. Prusiner S.B. Prions. Proc Natl Acad Sci USA 95 (1998) 13363-13383
52. Ebringer A., Rashid T., and Wilson C. Bovine spongiform encephalopathy as an autoimmune disease evoked by Acinetobacter: implications for multiple sclerosis and Creutzfeldt-Jakob disease. In: Shoenfeld Y., and Rose N. (Eds). Infection and autoimmunity (2004), Elsevier BV, Amsterdam 383-394
53. Will R.G., Ironside J.W., Zeidler M., et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347 (1996) 921-925
54. CJD Surveillance Unit. The National Creutzfeldt-Jakob Disease Surveillance Unit. Edinburgh, UK Figures. May 2006. Available from: http://www.cjd.ed.ac.uk/figures.htm.
55. Will R.G., Alperovitch A., Poser S., et al. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. Ann Neurol 43 (1998) 763-767
56. Cousens S.N., Linsell L., Smith P.G., et al. Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet 353 (1999) 18-21
57. Scholz R., and Lorenzen S. Phantom BSE-Gefahr (2005), Berenkamp, Innsbruck
58. Cousens S.N., Zeidler M., Esmonde T.F., et al. Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-1996. Br Med J 315 (1997) 389-395
59. Wientjens D.P., Davanipour Z., Hofman A., et al. Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology 46 (1996) 1287-1291
60. Eylar E.H., Caccam J., Jackson J.J., Westfall F.C., and Robinson A.B. Experimental allergic encephalomyelitis: synthesis of disease-inducing site of the basic protein. Science 168 (1970) 1220-1223
61. Ebringer A., Thorpe C., Pirt J., Wilson C., Cunningham P., and Ettelaie C. Bovine spongiform encephalopathy (BSE): is it an autoimmune disease due to bacteria showing molecular mimicry with brain antigens. Environ Health Perspect 105 (1997) 1172-1174
62. Wilson C., Hughes L.E., Rashid T., Ebringer A., and Bansal S. Antibodies to Acinetobacter bacteria and bovine brain peptides, measured in bovine spongiform encephalopathy (BSE) in an attempt to develop an ante-mortem test. J Clin Lab Immunol 52 (2003) 23-40
63. Nielsen K., Widdison J., Balachandran A., Stevenson D., and Algire J. Failure to demonstrate involvement of antibodies to Acinetobacter calcoaceticus in transmissible spongiform encephalopathies of animals. Vet Immunol Immunopathol 89 (2002) 197-205
64. Ebringer A., Hughes L., Rashid T., and Wilson C. Acinetobacter immune responses in multiple sclerosis: etiopathogenetic role and its possible use as a diagnostic marker. Arch Neurol 62 (2005) 33-36
65. Gay D., Dick G., and Upton G. Multiple sclerosis associated with sinusitis: case-controlled study in general practice. Lancet i (1986) 815-819
66. Jones R.L., Crowe P., Chavda S.V., and Pahor A.L. The incidence of sinusitis in patients with multiple sclerosis. Rhinology 35 (1997) 118-119
67. Bert F., and Lambert-Zechovsky N. Sinusitis in mechanically ventilated patients and its role in the pathogenesis of nosocomial pneumonia. Eur J Clin Microbiol Infect Dis 15 (1996) 533-544
68. Casiano R.R., Cohn S., and Villasuso III E. Comparison of antral tap with endoscopically directed nasal culture. Laryngoscope 111 (2001) 1333-1337
69. Lamoureux G., Lapierre Y., and Ducharme G. Past infectious events and disease evolution in multiple sclerosis. J Neurol 230 (1983) 81-90
70. Buljevac D., Flach H.Z., Hop W.C.J., et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 125 (2002) 952-960
71. Gilden D.H. Infectious causes of multiple sclerosis. Lancet Neurol 4 (2005) 195-202
72. Ergene E., Qualls C., Rupp F.W., and Ford C.C. Acute optic neuritis: association with paranasal sinus inflammatory changes on magnetic resonance imaging. J Neuroimag 10 (2000) 209-215
73. Awerbuch G., Labadie E.L., and van Dalen J.T.W. Reversible optic neuritis secondary to paranasal sinusitis. Eur Neurol 29 (1989) 189-193
74. Ebringer A., Rashid T., Wilson C., Boden R., and Thompson E. A possible link between multiple sclerosis is and Creutzfeldt-Jakob disease based on clinical, genetic, pathological and immunological evidence involving Acinetobacter bacteria. Med Hypotheses 64 (2005) 487-494
75. Ebringer A., Pirt J., and Wilson C. Bovine spongiform encephalopathy: comparison between the 'prion' hypothesis and the autoimmune theory. J Nutr Environ Med 8 (1998) 265-276
76. Chihota C.M., Gravenor M.B., and Baylis M. Investigation of trace elements in soil as risk factors in the epidemiology of scrapie. Vet Rec 154 (2004) 809-813
77. Ebringer A., Rashid T., and Wilson C. Molecular mimicry as the basis of a new theory of autoimmunity. In: Zouali M. (Ed). Frontiers in autoimmunity. Fundamental aspects and clinical prespectives (2003), IOS Press, Amsterdam 79-99
78. Kirvan C.A., Swedo S.E., Kurahara D., and Cunningham M.W. Streptococcal mimicry and antibody-mediated cell signalling in the pathogenesis of Sydenham's chorea. Autoimmunity 39 (2006) 21-29
79. Baker H.F., Ridley R.M., Wells G.A.H., and Ironside J.W. Prion protein immunohistochemical staining in the brains of monkeys with transmissible spongiform encephalopathy. Neuropathol Appl Neurobiol 24 (1998) 476-486
80. Legname G., Nguyen H.B., Baskakov I.V., Cohen F.E., DeArmond S.J., and Prusiner S.B. Strain-specific characteristics of mouse synthetic prions. Proc Natl Acad Sci USA 102 (2005) 2168-2173
81. DeArmond S.J., and Bouzamondo E. Fundamentals of prion biology and diseases. Toxicology 181 (2002) 9-16
82. Raine C.S., Cannella B., Hauser S.L., and Genain C.P. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann Neurol 46 (1999) 144-160
83. Zeine R., Cammer W., Barbarese E., Liu C., and Raine C.S. Structural dynamics of oligodendrocyte lysis by perforin in culture: relevance to multiple sclerosis. J Neurosci Res 64 (2001) 380-391
84. Lasmezas C.I., Deslys J., Robain O., et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275 (1997) 402-405
85. Correale J., and de los Milagros Bassani Molinas M. Oligoclonal bands and antibody responses in multiple sclerosis. J Neurol 249 (2002) 375-389
86. Graham D.I., and Lantos P.L. Greenfield's neuropathology (2002), London, Arnold
87. Filion L.G., Graziani-Bowering G.M., Matusevicius D., and Freedman M.S. Monocyte-derived cytokines in multiple sclerosis. Clin Exp Immunol 131 (2003) 324-334
88. Danilov A.I., Andersson M., Bavand N., Wiklund N.P., Olsson T., and Brundin L. Nitric oxide metabolic determinations reveal continuous inflammation in multiple sclerosis. J Neuroimmunol 136 (2003) 112-118
89. Aoki T., Gibbs C.J., Sotelo J., and Gajdusek D.C. Heterogeneic autoantibody against neurofilament protein in the sera of animals with experimental kuru, Creutzfeldt-Jakob disease and natural scrapie infection. Infect Immun 38 (1982) 316-324